Azenta, Inc. (NASDAQ:AZTA) Position Lessened by Rodgers Brothers Inc.

Rodgers Brothers Inc. decreased its position in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 43.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 24,175 shares of the company's stock after selling 18,565 shares during the period. Rodgers Brothers Inc. owned about 0.05% of Azenta worth $1,209,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of AZTA. Schroder Investment Management Group lifted its stake in Azenta by 46.7% during the fourth quarter. Schroder Investment Management Group now owns 1,405,056 shares of the company's stock worth $70,183,000 after purchasing an additional 447,292 shares during the last quarter. Norges Bank acquired a new position in shares of Azenta during the fourth quarter valued at $25,403,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in shares of Azenta by 14.9% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,446 shares of the company's stock valued at $225,000 after acquiring an additional 576 shares during the period. Zions Bancorporation N.A. increased its holdings in shares of Azenta by 15.8% in the 4th quarter. Zions Bancorporation N.A. now owns 27,678 shares of the company's stock worth $1,384,000 after acquiring an additional 3,774 shares during the period. Finally, Segall Bryant & Hamill LLC bought a new stake in Azenta in the 4th quarter valued at about $14,405,000. Institutional investors and hedge funds own 99.08% of the company's stock.

Azenta Price Performance

NASDAQ AZTA traded down $2.29 on Friday, hitting $29.01. 384,543 shares of the stock were exchanged, compared to its average volume of 610,158. The company's 50-day moving average price is $43.51 and its two-hundred day moving average price is $45.90. The company has a market capitalization of $1.33 billion, a price-to-earnings ratio of -9.73 and a beta of 1.52. Azenta, Inc. has a 52-week low of $27.88 and a 52-week high of $63.58.

Remove Ads

Azenta (NASDAQ:AZTA - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. Equities analysts predict that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Analyst Ratings Changes

Several research firms have commented on AZTA. Needham & Company LLC upped their target price on shares of Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a research report on Thursday, February 6th. TD Cowen raised Azenta to a "hold" rating in a report on Thursday, February 27th. Evercore ISI lifted their target price on Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a research note on Thursday, February 6th. Finally, Stephens reissued an "overweight" rating and issued a $60.00 price target on shares of Azenta in a research note on Thursday, January 2nd. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, Azenta presently has an average rating of "Hold" and an average price target of $58.75.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.